{
  "report_rows": [
    {
      "kpi": "Adjusted diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$2.11 vs. cons $2.08",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic sales growth",
      "prediction": "IN-LINE",
      "answer": "pred ~4.5% vs. cons 4.6%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted operating-income margin",
      "prediction": "BEAT",
      "answer": "pred ~17.2% vs. cons 17.0%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Full-year 2026 adjusted diluted EPS outlook, excluding CoolIT",
      "prediction": "UNCHANGED",
      "answer": "guide ~$8.53 midpoint vs. cons $8.54 (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Second-half organic sales-growth outlook",
      "prediction": "BETTER",
      "answer": "guide ~6.5% vs. cons 6.3% (2H2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Third-quarter adjusted diluted EPS outlook, excluding CoolIT",
      "prediction": "LOWER",
      "answer": "guide ~$2.29 midpoint vs. cons $2.33 (3Q2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 1.8,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 1.2,
  "day5_path": "STABILIZE",
  "day5_rationale": "A ~$2.11 vs. $2.08 EPS beat and ~17.2% vs. 17.0% margin support an initial positive move, but unchanged ~$8.53 vs. $8.54 FY2026 EPS and a ~$2.29 vs. $2.33 3Q outlook limit out-period estimate revisions.",
  "day5_confidence": "MEDIUM"
}